Release Date: 24/11/16 08:26 Summary: Operations Update - Additional Toll Treatment Price Sensitive: Yes Download Document 473.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%